Cargando…
Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data
BACKGROUND: Rapid diagnostic tests (RDTs) for malaria are a vital part of global malaria control. Over the past decade, RDT prices have declined, and quality has improved. However, the relationship between price and product quality and their larger implications on the market have yet to be character...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752184/ https://www.ncbi.nlm.nih.gov/pubmed/35016684 http://dx.doi.org/10.1186/s12936-021-04008-2 |
_version_ | 1784631833547243520 |
---|---|
author | Wittenauer, Rachel Nowak, Spike Luter, Nick |
author_facet | Wittenauer, Rachel Nowak, Spike Luter, Nick |
author_sort | Wittenauer, Rachel |
collection | PubMed |
description | BACKGROUND: Rapid diagnostic tests (RDTs) for malaria are a vital part of global malaria control. Over the past decade, RDT prices have declined, and quality has improved. However, the relationship between price and product quality and their larger implications on the market have yet to be characterized. This analysis used purchase data from the Global Fund together with product quality data from the World Health Organization (WHO) and Foundation for Innovative New Diagnostics (FIND) Malaria RDT Product Testing Programme to understand three unanswered questions: (1) Has the market share by quality of RDTs in the Global Fund’s procurement orders changed over time? (2) What is the relationship between unit price and RDT quality? (3) Has the market for RDTs financed by the Global Fund become more concentrated over time? METHODS: Data from 10,075 procurement transactions in the Global Fund’s database, which includes year, product, volume, and price, was merged with product quality data from all eight rounds of the WHO-FIND programme, which evaluated 227 unique RDT products. To describe trends in market share by quality level of RDT, descriptive statistics were used to analyse trends in market share from 2009 to 2018. A generalized linear regression model was then applied to characterize the relationship between price and panel detection score (PDS), adjusting for order volume, year purchased, product type, and manufacturer. Third, a Herfindahl–Hirschman Index (HHI) score was calculated to characterize the degree of market concentration. RESULTS: Lower-quality RDTs have lost market share between 2009 and 2018, as have the highest-quality RDTs. No statistically significant relationship between price per test and PDS was found when adjusting for order volume, product type, and year of purchase. The HHI was 3,570, indicating a highly concentrated market. CONCLUSIONS: Advancements in RDT affordability, quality, and access over the past decade risk stagnation if health of the RDT market as a whole is neglected. These results suggest that from 2009 to 2018, this market was highly concentrated and that quality was not a distinguishing feature between RDTs. This information adds to previous reports noting concerns about the long-term sustainability of this market. Further research is needed to understand the causes and implications of these trends. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-04008-2. |
format | Online Article Text |
id | pubmed-8752184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87521842022-01-12 Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data Wittenauer, Rachel Nowak, Spike Luter, Nick Malar J Research BACKGROUND: Rapid diagnostic tests (RDTs) for malaria are a vital part of global malaria control. Over the past decade, RDT prices have declined, and quality has improved. However, the relationship between price and product quality and their larger implications on the market have yet to be characterized. This analysis used purchase data from the Global Fund together with product quality data from the World Health Organization (WHO) and Foundation for Innovative New Diagnostics (FIND) Malaria RDT Product Testing Programme to understand three unanswered questions: (1) Has the market share by quality of RDTs in the Global Fund’s procurement orders changed over time? (2) What is the relationship between unit price and RDT quality? (3) Has the market for RDTs financed by the Global Fund become more concentrated over time? METHODS: Data from 10,075 procurement transactions in the Global Fund’s database, which includes year, product, volume, and price, was merged with product quality data from all eight rounds of the WHO-FIND programme, which evaluated 227 unique RDT products. To describe trends in market share by quality level of RDT, descriptive statistics were used to analyse trends in market share from 2009 to 2018. A generalized linear regression model was then applied to characterize the relationship between price and panel detection score (PDS), adjusting for order volume, year purchased, product type, and manufacturer. Third, a Herfindahl–Hirschman Index (HHI) score was calculated to characterize the degree of market concentration. RESULTS: Lower-quality RDTs have lost market share between 2009 and 2018, as have the highest-quality RDTs. No statistically significant relationship between price per test and PDS was found when adjusting for order volume, product type, and year of purchase. The HHI was 3,570, indicating a highly concentrated market. CONCLUSIONS: Advancements in RDT affordability, quality, and access over the past decade risk stagnation if health of the RDT market as a whole is neglected. These results suggest that from 2009 to 2018, this market was highly concentrated and that quality was not a distinguishing feature between RDTs. This information adds to previous reports noting concerns about the long-term sustainability of this market. Further research is needed to understand the causes and implications of these trends. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-021-04008-2. BioMed Central 2022-01-12 /pmc/articles/PMC8752184/ /pubmed/35016684 http://dx.doi.org/10.1186/s12936-021-04008-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wittenauer, Rachel Nowak, Spike Luter, Nick Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data |
title | Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data |
title_full | Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data |
title_fullStr | Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data |
title_full_unstemmed | Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data |
title_short | Price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of Global Fund 2009–2018 data |
title_sort | price, quality, and market dynamics of malaria rapid diagnostic tests: analysis of global fund 2009–2018 data |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752184/ https://www.ncbi.nlm.nih.gov/pubmed/35016684 http://dx.doi.org/10.1186/s12936-021-04008-2 |
work_keys_str_mv | AT wittenauerrachel pricequalityandmarketdynamicsofmalariarapiddiagnostictestsanalysisofglobalfund20092018data AT nowakspike pricequalityandmarketdynamicsofmalariarapiddiagnostictestsanalysisofglobalfund20092018data AT luternick pricequalityandmarketdynamicsofmalariarapiddiagnostictestsanalysisofglobalfund20092018data |